Fruquintinib functions by inhibiting the formation of new blood vessels in tumours. Credit: Jo Panuwat D/Shutterstock. Takeda ...

The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...

Zevra Therapeutics has gained FDA approval for Miplyffa (arimoclomol) to treat Niemann-Pick disease type C (NPC).

C-realize provides software solutions to help pharmaceutical clients improve product development and meet regulatory standards. C-realize works as an IT partner for the pharmaceutical, biotechnology, ...

Bavarian Nordic’s MVA-BN vaccine is called Imvanex in Europe but is known as Jynneos in countries such as the US and ...

Orbis Medicines and Vivtex have partnered to support the development of next-generation orally dosable macrocycle drugs.

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended an update to Novo ...

After missing primary endpoints in relapsing forms of MS, tolebrutinib has proved its efficacy in secondary progressive MS ...

The growth of AI in the healthcare sector is already having real-world impacts and promises a step-change in future care.

The US FDA has declined to approve the NDA submitted by Vanda Pharmaceuticals for tradipitant to treat gastroparesis symptoms ...

NanoVation will receive $600m in upfront cash and potential milestone payments, as well as tiered royalties on future product ...

The biotech has secured $65m in a Series A funding round led by Cormorant Asset Management and other investors.